Results 51 to 60 of about 1,633 (148)
Pediatric patients with von Hippel–Lindau and hemangioblastomas treated successfully with belzutifan
Abstract Hemangioblastoma is the most common tumor associated with von Hippel–Lindau (VHL), and are a leading cause of mortality. We present five pediatric patients with VHL‐associated hemangioblastomas treated with belzutifan, a hypoxia‐inducible factor 2a (HIF2a) inhibitor. Three patients were started on belzutifan due to vision loss from progressive
Emily Duan +10 more
wiley +1 more source
Retinal vascular proliferation with fibrotic regression in von Hippel–Lindau disease
In this study, we report a rare case of retinal vascular proliferation (RVP) in von Hippel–Lindau (VHL) disease, followed by a literature review. A 12-year-old boy presented with a left cerebellar hemangioblastoma and right eye blurred vision for 1–2 ...
Jing-Yi Chen +4 more
doaj +1 more source
Juxtapapillary Hemangioblastoma: Case Report and Review of Literature
Purpose: To report a case of retinal vascular tumor and to review literature pertaining to management of retinal vascular tumors of the eye. Methods: Clinical data including medical history, findings on physical examination, local examination, Fundus ...
Anurag Narula +5 more
doaj +1 more source
Clinical and Genetic Characteristics of Retinal Capillary Hemangioblastoma in Korean Patients
Purpose: We investigated the clinical features of Korean patients with retinal capillary hemangioblastoma (RCH) and genetic variants of the von Hippel-Lindau (<i>VHL</i>) gene.Methods: A retrospective analysis was performed on patients with RCH from 2003 to 2021 at Seoul National University Bundang Hospital.
Lee, Sang Ha +4 more
openaire +2 more sources
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome characterized by poor survival. The effect of the involvement of each organ on survival remains unclear.
Bowen Zhou +30 more
doaj +1 more source
The evolving landscape of tissue‐agnostic therapies in precision oncology
ABSTRACT Tumor‐agnostic therapies represent a paradigm shift in oncology by altering the traditional means of characterizing tumors based on their origin or location. Instead, they zero in on specific genetic anomalies responsible for fueling malignant growth.
Vivek Subbiah +4 more
wiley +1 more source
Pancreatic Involvement in von Hippel Lindau Disease: A Single‐Center Experience
JGH Open, Volume 10, Issue 2, February 2026.
Ali Emre Bardak +5 more
wiley +1 more source
Key Clinical Message Pituitary apoplexy is a medical and surgical emergency requiring prompt diagnosis and often urgent treatment to manage symptoms and prevent further complications. Abstract This report describes the successful management of a 37‐year‐old pregnant woman with a history of pituitary macroadenoma and apoplexy during a twin pregnancy ...
Ujjwal Kumar Jha +2 more
wiley +1 more source
Whole-Genome Landscape of Retinal Hemangioblastomas
Retinal hemangioblastomas (RHs) are rare benign vascular tumors that present mostly as manifestations of Von Hippel-Lindau (VHL) syndrome. In contrast to other VHL syndrome-associated tumors, only a handful of molecular studies have been published on RHs.
Bals, Kiki +12 more
openaire +4 more sources
In this series, we discuss the role of optical coherence tomography angiography (OCTA) in assessing response to treatment in intraocular vascular tumors.
Pradeep Sagar +5 more
doaj +1 more source

